Corpus Intelligence IC Memo — ARMSTRONG COUNTY MEMORIAL 2026-04-27 01:25 UTC
IC Memo — ARMSTRONG COUNTY MEMORIAL
Investment Committee Memorandum | PA | 95 beds | Grade D | EBITDA uplift $8.8M
🛡️ Public data only — no PHI permitted on this instance.
INVESTMENT COMMITTEE MEMORANDUM  ·  CCN 390163

ARMSTRONG COUNTY MEMORIAL

LOCATIONARMSTRONG, PA·BEDS95·AS OFApril 27, 2026
D
INVESTABILITY
EBITDA BridgeData Room

1. Target Overview & Investment Thesis

ARMSTRONG COUNTY MEMORIAL is a 95-bed community hospital in ARMSTRONG, PA with $119.9M in net patient revenue and a -27.0% operating margin. The hospital serves a payer mix of 0.0% Medicare, 0.7% Medicaid, and 99.3% commercial.

Thesis: Turnaround. Our ML models identify $8.8M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -27.0% to -19.6% (+736bps).

Net Revenue HCRIS$119.9M
Current EBITDA COMPUTED$-32.4M
Operating Margin COMPUTED-27.0%
Occupancy HCRIS43.7%
Revenue / Bed COMPUTED$1.3M
Net-to-Gross HCRIS25.9%
Distress Probability MLnan%

2. Market Context & Competitive Position

225
PA Hospitals
-4.4%
State Median Margin
105
Comparable Hospitals

PA has 225 Medicare-certified hospitals with a median operating margin of -4.4%. The target's margin of -27.0% places it below the state median. Among 105 size-comparable peers (48-190 beds), the median margin is -6.2%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (48-190), prioritizing same-state peers. 105 hospitals in the comp set.

HospitalStateBedsRevenueMargin
ARMSTRONG COUNTY MEMORIAL (Target)PA95$119.9M-27.0%
THE GETTYSBURG HOSPITALPA76$341.8M18.4%
ST. JOSEPH MEDICAL CENTERPA132$334.8M13.2%
EPHRATA COMMUNITY HOSPITALPA115$291.8M3.8%
EINSTEIN MEDICAL CENTER MONTGOPA175$276.3M6.9%
THE GOOD SAMARITAN HOSPITALPA145$269.5M-5.0%
WILKES-BARRE GENERAL HOSPITALPA188$262.1M-13.0%
UPMC ST MARGARETPA185$248.5M-21.3%
RIDDLE HOSPITALPA186$238.1M-12.1%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $8.8M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$2.5M+210bp18mo
Cost to Collect4.5%2.5%$2.4M+200bp12mo
Denial Rate Reduction12.0%6.5%$2.4M+198bp12mo
A/R Days Reduction5200.0%3800.0%$1.5M+122bp9mo
Clean Claim Rate88.0%96.0%$77K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$2.5M
Cost to Collect
$2.4M
Denial Rate Reduction
$2.4M
A/R Days Reduction
$1.5M
Clean Claim Rate
$77K
Total EBITDA Uplift$8.8M
Current EBITDA$-32.4M
+ RCM Uplift+$8.8M
Pro Forma EBITDA$-23.6M
Current Margin-27.0%
Pro Forma Margin-19.6%
WC Released (1x)$4.6M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-49.8M$-125.3M0.00x-100.0%
Base (11x exit)10.0x11.0x$-49.8M$-154.0M0.00x-100.0%
Bull Case9.0x11.0x$-44.8M$-141.1M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-44.8M$-167.1M0.00x-100.0%
Bear Case11.0x10.0x$-54.8M$-153.3M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-54.8M$-186.4M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 105 hospitals with 48-190 beds
  • Same-state prioritization (n=106)
  • Comp margins: P25=-20.9% / P50=-6.2% / P75=8.0%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 27, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.